Medication-Related Osteonecrosis of the Jaw: Important Clinical Considerations

Authors

Bard J. Levey DDS, University of Tennessee College of DentistryFollow
Franklin Garcia-Godoy DS, MS, PhD, University of Tennessee Department of Bioscience ResearchFollow

Keywords

medication related osteonecrosis of the jaw (MRONJ), bisphosphonates, CT imaging

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a challenging condition for dental practitioners. Despite the plethora of published literature on this topic, widespread clinical awareness and recognition is still not common as clinicians still do not recognize the common, early presentations of this disease. This has been shown in different studies conducted in different parts of the world.1-4 The present paper highlights the important clinical considerations for practitioners to evaluate.

Recommended Citation

Levey, Bard J. DDS and Garcia-Godoy, Franklin DS, MS, PhD (2022) "Medication-Related Osteonecrosis of the Jaw: Important Clinical Considerations," The New York State Dental Journal: Vol. 88: No. 4, Article 4.
Available at: https://commons.ada.org/nysdj/vol88/iss4/4